Chonglei Bi

1.6k total citations
35 papers, 1.3k citations indexed

About

Chonglei Bi is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Chonglei Bi has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Hematology and 11 papers in Cancer Research. Recurrent topics in Chonglei Bi's work include Acute Myeloid Leukemia Research (8 papers), Multiple Myeloma Research and Treatments (6 papers) and MicroRNA in disease regulation (5 papers). Chonglei Bi is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Multiple Myeloma Research and Treatments (6 papers) and MicroRNA in disease regulation (5 papers). Chonglei Bi collaborates with scholars based in Singapore, United States and China. Chonglei Bi's co-authors include Wee Joo Chng, Jianbiao Zhou, Qiang Yu, Junli Yan, Gaofeng Huang, Sylvia Mahara, Joy Tan, Siok‐Bian Ng, Viknesvaran Selvarajan and Shaw-Cheng Liu and has published in prestigious journals such as Blood, PLoS ONE and Molecular Cancer.

In The Last Decade

Chonglei Bi

33 papers receiving 1.3k citations

Peers

Chonglei Bi

HEMAT

ONCOL

PFM

Masato Shikami Japan

Valerie Grose United States

Oliver Galm Germany

Simon Bomken United Kingdom

Magdalena Plašilová United States

Rodney R. Miles United States

Claire Seedhouse United Kingdom

Shenmeng Gao China

Masato Shikami Japan

Chonglei Bi

703 ×0.8

451 ×1.4

HEMAT

209 ×0.7

381 ×1.4

ONCOL

73 ×0.4

PFM

Citations per year, relative to Chonglei Bi Chonglei Bi (= 1×) peers Masato Shikami

Countries citing papers authored by Chonglei Bi

Since Specialization

Citations

This map shows the geographic impact of Chonglei Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chonglei Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chonglei Bi more than expected).

Fields of papers citing papers by Chonglei Bi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chonglei Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chonglei Bi. The network helps show where Chonglei Bi may publish in the future.

Co-authorship network of co-authors of Chonglei Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Chonglei Bi. A scholar is included among the top collaborators of Chonglei Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chonglei Bi. Chonglei Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ding, Congcong, Chonglei Bi, Teng-Fei Lin, et al.. (2022). Association between serum calcium levels and first stroke: A community-based nested case-control study. Frontiers in Neurology. 13. 938794–938794. 3 indexed citations

Zhou, Ziyi, Nan Zhang, Teng-Fei Lin, et al.. (2022). Plasma 25-hydroxyvitamin D3 concentrations and incident risk of ischemic stroke in rural Chinese adults: New insight on ceiling effect. Nutrition. 99-100. 111627–111627. 2 indexed citations

Hu, Lihua, Chonglei Bi, Lishun Liu, et al.. (2021). Association between baseline brachial–ankle pulse wave velocity and short-term risk of first stroke among Chinese hypertensive adults. Journal of Human Hypertension. 36(12). 1085–1091. 2 indexed citations

Hu, Huanhuan, Chonglei Bi, Teng-Fei Lin, et al.. (2021). Sex difference in the association between plasma selenium and first stroke: a community-based nested case-control study. Biology of Sex Differences. 12(1). 39–39. 17 indexed citations

Hu, Lihua, Chonglei Bi, Teng-Fei Lin, et al.. (2021). Association between plasma copper levels and first stroke: a community-based nested case–control study. Nutritional Neuroscience. 25(7). 1524–1533. 24 indexed citations

Zhang, Yue, Jingyi Li, Chengzhang Liu, et al.. (2021). High-Density Lipoprotein Cholesterol and the Risk of First Ischemic Stroke in a Chinese Hypertensive Population. Clinical Interventions in Aging. Volume 16. 801–810. 12 indexed citations

Ding, Congcong, Chonglei Bi, Teng-Fei Lin, et al.. (2020). Serum folate modified the association between low-density lipoprotein cholesterol and carotid intima-media thickness in Chinese hypertensive adults. Nutrition Metabolism and Cardiovascular Diseases. 30(12). 2303–2311. 4 indexed citations

Zhou, Jianbiao, Chonglei Bi, Jing-Yuan Chooi, et al.. (2017). Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia. Journal of Hematology & Oncology. 10(1). 138–138. 63 indexed citations

Mustafa, Nurulhuda, et al.. (2017). VS-5584 mediates potent anti-myeloma activity via the upregulation of a class II tumor suppressor gene, RARRES3 and the activation of Bim. Oncotarget. 8(60). 101847–101864. 6 indexed citations

10.

Zhou, Jianbiao, Chonglei Bi, Phyllis S.Y. Chong, et al.. (2016). LIN28B Activation by PRL-3 Promotes Leukemogenesis and a Stem Cell–like Transcriptional Program in AML. Molecular Cancer Research. 15(3). 294–303. 30 indexed citations

11.

Yan, Junli, Boheng Li, Tae‐Hoon Chung, et al.. (2016). EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma. Blood. 128(7). 948–958. 106 indexed citations

12.

Kong, Li Ren, Kian Ngiap Chua, Wen Jing Sim, et al.. (2015). MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma. Molecular Cancer Therapeutics. 14(7). 1750–1760. 41 indexed citations

13.

Xie, Zhigang, et al.. (2015). MMSET regulates expression of IRF4 in t(4;14) myeloma and its silencing potentiates the effect of bortezomib. Leukemia. 29(12). 2347–2354. 25 indexed citations

14.

Zhou, Jianbiao, Phyllis S.Y. Chong, Chonglei Bi, et al.. (2014). Phosphatase of regenerating liver-3 is regulated by signal transducer and activator of transcription 3 in acute myeloid leukemia. Experimental Hematology. 42(12). 1041–1052.e2. 21 indexed citations

15.

Yan, Junli, Nan Jiang, Gaofeng Huang, et al.. (2013). Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia. British Journal of Haematology. 163(1). 93–103. 35 indexed citations

16.

Zhou, Jianbiao, Phyllis S.Y. Chong, Sylvia Mahara, et al.. (2012). The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia. Molecular Cancer. 11(1). 72–72. 30 indexed citations

17.

Zhou, Jianbiao, Chonglei Bi, Wee Joo Chng, et al.. (2011). PRL-3, a Metastasis Associated Tyrosine Phosphatase, Is Involved in FLT3-ITD Signaling and Implicated in Anti-AML Therapy. PLoS ONE. 6(5). e19798–e19798. 58 indexed citations

18.

Zhou, Jianbiao, et al.. (2011). The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML. Blood. 118(10). 2830–2839. 182 indexed citations

19.

Xie, Zhigang, Chonglei Bi, Gaofeng Huang, et al.. (2011). Determinants of Sensitivity to DZNep Induced Apoptosis in Multiple Myeloma Cells. PLoS ONE. 6(6). e21583–e21583. 32 indexed citations

20.

Zhou, Jianbiao, Viraj J. Jasinghe, Chonglei Bi, et al.. (2008). In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor. Leukemia Research. 32(7). 1091–1100. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact